Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications
Several animal and human studies have implicated CD4+ T helper 17 (Th17) cells and their downstream pathways in the pathogenesis of central nervous system (CNS) autoimmunity in multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD), challenging the traditional Th1-Th2 paradigm....
Saved in:
Main Authors: | Giordani Rodrigues Dos Passos (Author), Douglas Kazutoshi Sato (Author), Jefferson Becker (Author), Kazuo Fujihara (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuromyelitis Optica Spectrum Disorders - from pathophysiology to treatment
by: Jessica Adriana Kałuża, et al.
Published: (2024) -
Pediatric neuromyelitis optica spectrum disorder
by: Aman Mehta
Published: (2024) -
Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
by: Xueli Fan, et al.
Published: (2016) -
Neuromyelitis Optica in a Young Woman With Tuberous Sclerosis: Is There an Association?
by: Mahmoud Elkhooly MD, et al.
Published: (2022) -
Prognosis of Relapsing Neuromyelitis Optica
by: J Gordon Millichap
Published: (2003)